Wird geladen...
In silico prediction of cancer immunogens: current state of the art
Cancer kills 8 million annually worldwide. Although survival rates in prevalent cancers continue to increase, many cancers have no effective treatment, prompting the search for new and improved protocols. Immunotherapy is a new and exciting addition to the anti-cancer arsenal. The successful and acc...
Gespeichert in:
| Veröffentlicht in: | BMC Immunol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856276/ https://ncbi.nlm.nih.gov/pubmed/29544447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-018-0248-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|